Keros Therapeutics, Inc.

NASDAQ:KROS

14.21 (USD) • At close April 25, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024202320222021202020192018
Operating Activities:
Net Income -187.353-152.992-104.679-58.744-45.361-12.336-1.335
Depreciation & Amortization 1.2290.8150.6740.3780.2780.2080.153
Deferred Income Tax 0000.046000
Stock Based Compensation 34.87228.76318.68211.7224.0970.0590.081
Change In Working Capital -11.437-2.6514.308-16.072.275-6.7247.949
Accounts Receivables -2.599-0.14318-180.922-0.552-0.37
Inventory 0-4.50501.042-0.9220.5520
Accounts Payables -0.2491.614-0.4081.4850.0611.312-0.002
Other Working Capital -8.5890.384-3.284-0.5972.214-8.0367.951
Other Non Cash Items 1.821.5560.9530.521.8172.7950.194
Operating Cash Flow -160.869-124.508-70.062-62.148-36.894-15.9987.042
Investing Activities:
Investments In Property Plant And Equipment -1.931-2.464-1.241-1.024-0.294-0.271-0.217
Acquisitions Net 0000000
Purchases Of Investments 0000000
Sales Maturities Of Investments 0000000
Other Investing Activites 0000000
Investing Cash Flow -1.931-2.464-1.241-1.024-0.294-0.271-0.217
Financing Activities:
Debt Repayment 0000000
Common Stock Issued 380.134175.825119.57828.171243.2020.01411.463
Common Stock Repurchased 0000000
Dividends Paid 0000000
Other Financing Activities 11.6873.1310.7310.37952.8420.01411.463
Financing Cash Flow 391.821178.956120.30928.55296.0440.01411.463
Other Information:
Effect Of Forex Changes On Cash 0000000
Net Change In Cash 229.02151.98449.006-34.622258.856-16.25518.288
Cash At End Of Period 561.38332.359280.375231.369265.9917.13523.39